MBP7 [5011]
MBP7
| SMILES | CC(C)C[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CO)C(=O)O |
| InChIKey | NZCFITBCFLGDFN-JEDGRRCBSA-N |
| Sequence | KAQLRRLS |
| HELM | PEPTIDE1{K.A.Q.L.R.R.L.S}$$$$ |
Chemical Properties
| Hydrogen bond acceptors | 14 |
| Hydrogen bond donors | 16 |
| Rotatable bonds | 35 |
| Log P | -5.602 |
| Molecular weight (Da) | 970.6 |
| Stereochemistry info | unspecified |
Database connections
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
MBP7
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0